Published in Proc Natl Acad Sci U S A on December 01, 1976
Disrupted prediction-error signal in psychosis: evidence for an associative account of delusions. Brain (2007) 2.77
New detection of brain dopamine receptors with (3H)dihydroergocryptine. Proc Natl Acad Sci U S A (1977) 1.28
Resolution of dopamine and serotonin receptor components of [3H]spiperone binding to rat brain regions. Proc Natl Acad Sci U S A (1981) 1.12
Multiple receptors for brain dopamine. Proc Natl Acad Sci U S A (1978) 1.11
Agonist high- and low-affinity states of dopamine D₂ receptors: methods of detection and clinical implications. Naunyn Schmiedebergs Arch Pharmacol (2012) 0.86
Abnormal negative feedback processing in first episode schizophrenia: evidence from an oculomotor rule switching task. Psychol Med (2011) 0.79
Solubilization of dopamine-D2 receptors from synaptosomal membranes of the bovine caudate nucleus. Br J Pharmacol (1984) 0.77
The use of ADTN (2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene) as a ligand for brain dopamine receptors [proceedings]. Br J Pharmacol (1979) 0.75
Some neuropharmacological aspects of schizophrenia: a short review. Ir J Med Sci (1978) 0.75
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol (1973) 47.81
The membrane actions of anesthetics and tranquilizers. Pharmacol Rev (1972) 11.00
Dopamine (3-hydroxytyramine) and brain function. Pharmacol Rev (1966) 4.55
Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science (1976) 4.07
Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature (1976) 2.85
The displacement of membrane calcium by a local anesthetic (chlorpromazine). Biochim Biophys Acta (1969) 2.83
Stereospecific and nonspecific interactions of the morphine congener levorphanol in subcellular fractions of mouse brain. Proc Natl Acad Sci U S A (1971) 2.82
Identification of beta-adrenergic receptors in human lymphocytes by (-) (3H) alprenolol binding. J Clin Invest (1976) 2.58
Brain receptors for antipsychotic drugs and dopamine: direct binding assays. Proc Natl Acad Sci U S A (1975) 2.16
Membrane stabilization by drugs: tranquilizers, steroids, and anesthetics. Int Rev Neurobiol (1966) 2.10
Evidence for dopamine receptor stimulation by apomorphine. J Pharm Pharmacol (1967) 2.08
Serotonin and lysergic acid diethylamide binding in rat brain membranes: relationship to postsynaptic serotonin receptors. Mol Pharmacol (1976) 1.93
Mode of action of apomorphine and dexamphetamine on gnawing compulsion in rats. Psychopharmacologia (1967) 1.89
Dopamine receptors in the brain. Science (1975) 1.79
The dopamine hypothesis of schizophrenia: focus on the dopamine receptor. Am J Psychiatry (1976) 1.78
Dopamine-sensitive adenylate cyclase in mammalian brain: a possible site of action of antipsychotic drugs. Proc Natl Acad Sci U S A (1974) 1.63
Solubilization and characterization of the beta-adrenergic receptor binding sites of frog erythrocytes. J Biol Chem (1976) 1.52
Antipsychotic drug actions: a clue to the neuropathology of schizophrenia? Fed Proc (1973) 1.33
Dopamine receptor binding in the corpus striatum of mammalian brain. Proc Natl Acad Sci U S A (1975) 1.29
The dopamine receptor: differential binding of d-LSD and related agents to agonist and antagonist states. Life Sci (1975) 1.29
The membrane concentrations of alcohol anesthetics. Biochim Biophys Acta (1971) 1.27
The effect of neuroleptics on serum prolactin in schizophrenic patients. Arch Gen Psychiatry (1976) 1.25
Antagonistic effects of apomorphine and haloperidol on rat striatal synaptosomal tyrosine hydroxylase. J Pharm Pharmacol (1974) 1.23
Antipsychotic drugs and dopamine-stimulated adenylate cyclase prepared from corpus striatum of rat brain. Proc Natl Acad Sci U S A (1974) 1.20
The nerve impulse-blocking actions of tranquilizers and the binding of neuroleptics to synaptosome membranes. J Pharmacol Exp Ther (1974) 1.03
Effect of butaclamol and its enantiomers upon striatal homovanillic acid and adenyl cyclase of olfactory tubercle in rats. Life Sci (1975) 1.01
Neuroleptic agents of the benzocycloheptapyridoisoquinoline series. 1. Syntheses and stereochemical and structural requirements for activity of butaclamol and related compounds. J Med Chem (1975) 0.92
Tardive and withdrawal dyskinesia associated with haloperidol. Am J Psychiatry (1974) 0.88
The behavioral pharmacology of butaclamol hydrochloride (AY-23,028), a new potent neuroleptic drug. Psychopharmacologia (1975) 0.84
Butaclamol hydrochloride (AY-23,028): an early evaluation in severely ill schizophrenics. Dis Nerv Syst (1975) 0.83
Enhanced binding of chlorpromazine to cholesterol-depleted synaptosome fractions. Can J Physiol Pharmacol (1974) 0.79
Dopamine-sensitive adenylyl cyclase in human caudate nucleus. A study in control subjects and schizophrenic patients. Arch Gen Psychiatry (1975) 0.79
Dopamine receptor blockade and the neuroleptics, a crystallographic study. J Pharm Pharmacol (1975) 0.79
Effect of morphine on the transport of dopamine into mouse brain slices. Eur J Pharmacol (1973) 0.78
The membrane actions of anesthetics and tranquilizers. Pharmacol Rev (1972) 11.00
The composite genome of the legume symbiont Sinorhizobium meliloti. Science (2001) 9.11
Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature (1991) 4.36
Multiple dopamine D4 receptor variants in the human population. Nature (1992) 4.08
Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis. Am J Psychiatry (2001) 3.66
Directional guidance of neuronal migration in the olfactory system by the protein Slit. Nature (1999) 3.51
Gene expression profiling of cells, tissues, and developmental stages of the nematode C. elegans. Cold Spring Harb Symp Quant Biol (2003) 3.22
Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons. Science (1975) 3.12
Repression of c-myc transcription by Blimp-1, an inducer of terminal B cell differentiation. Science (1997) 2.93
Brain dopamine receptors. Pharmacol Rev (1980) 2.88
Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature (1976) 2.85
The displacement of membrane calcium by a local anesthetic (chlorpromazine). Biochim Biophys Acta (1969) 2.83
The components of synaptic potentials evoked in cat spinal motoneurones by impulses in single group Ia afferents. J Physiol (1981) 2.83
Prostasin, a potential serum marker for ovarian cancer: identification through microarray technology. J Natl Cancer Inst (2001) 2.83
Free radicals and inflammation: superoxide-dependent activation of a neutrophil chemotactic factor in plasma. Proc Natl Acad Sci U S A (1980) 2.75
The complete sequence of the 1,683-kb pSymB megaplasmid from the N2-fixing endosymbiont Sinorhizobium meliloti. Proc Natl Acad Sci U S A (2001) 2.46
Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1. Nature (1991) 2.41
Transient holes in the erythrocyte membrane during hypotonic hemolysis and stable holes in the membrane after lysis by saponin and lysolecithin. J Cell Biol (1967) 2.40
Membrane formation by the adenosine triphosphatase of sarcoplasmic reticulum. J Biol Chem (1971) 2.34
Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism? Mol Genet Metab (2003) 2.29
Radioreceptor binding profile of the atypical antipsychotic olanzapine. Neuropsychopharmacology (1996) 2.18
The proton relaxation of benzyl alcohol in erythrocyte membranes. Mol Pharmacol (1968) 2.17
Brain receptors for antipsychotic drugs and dopamine: direct binding assays. Proc Natl Acad Sci U S A (1975) 2.16
A standardized, uniform and universal dental chart for documenting state of dentition before anaesthesia. Anaesth Intensive Care (2001) 2.16
Cancer: To tell or not to tell? Singapore Med J (1993) 2.10
The membrane concentrations of neutral and positive anesthetics (alcohols, chlorpromazine, morphine) fit the Meyer-Overton rule of anesthesia; negative narcotics do not. Biochim Biophys Acta (1972) 2.02
Selective media for the quantitation of bacteria in cystic fibrosis sputum. J Med Microbiol (1984) 1.95
A novel link between integrins, transmembrane-4 superfamily proteins (CD63 and CD81), and phosphatidylinositol 4-kinase. J Biol Chem (1997) 1.92
A novel tetrodotoxin-sensitive, voltage-gated sodium channel expressed in rat and human dorsal root ganglia. J Biol Chem (1997) 1.91
Identification of the major synaptojanin-binding proteins in brain. J Biol Chem (1997) 1.88
The membrane concentration of a local anesthetic (chlorpromazine). Biochim Biophys Acta (1969) 1.86
Anti-schizophrenic drugs--membrane receptor sites of action. Biochem Pharmacol (1977) 1.85
Byr4 and Cdc16 form a two-component GTPase-activating protein for the Spg1 GTPase that controls septation in fission yeast. Curr Biol (1998) 1.83
Identification of a cAMP-dependent protein kinase catalytic subunit required for virulence and morphogenesis in Ustilago maydis. Proc Natl Acad Sci U S A (1998) 1.77
Glioblastoma multiforme: radiologic-pathologic correlation. Radiographics (1996) 1.76
In vitro synthesis of IgE by human lymphocytes. II. Enhancement of the spontaneous IgE synthesis by IgE-binding factors secreted by RPMI 8866 lymphoblastoid B cells. Immunology (1984) 1.75
Erythropoietin and erythropoietin receptor expression in human cancer. Cancer Res (2001) 1.74
Mortality studies in psoriatic arthritis: results from a single outpatient center. II. Prognostic indicators for death. Arthritis Rheum (1998) 1.73
CT angiography clot burden score and collateral score: correlation with clinical and radiologic outcomes in acute middle cerebral artery infarct. AJNR Am J Neuroradiol (2009) 1.72
A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy. Arch Gen Psychiatry (2000) 1.71
Gene polymorphism in Netherton and common atopic disease. Nat Genet (2001) 1.66
Ultrastructure of membrane lesions in immune lysis, osmotic lysis and drug-induced lysis. Fed Proc (1974) 1.64
The Trace Amine 1 receptor knockout mouse: an animal model with relevance to schizophrenia. Genes Brain Behav (2006) 1.63
D1 and D2 dopamine receptor mRNA in rat brain. Proc Natl Acad Sci U S A (1991) 1.55
The mating-type and pathogenicity locus of the fungus Ustilago hordei spans a 500-kb region. Proc Natl Acad Sci U S A (1999) 1.55
Modifications to synaptic transmission at group Ia synapses on cat spinal motoneurones by 4-aminopyridine. J Physiol (1981) 1.54
Receptor basis for dopaminergic supersensitivity in Parkinson's disease. Nature (1978) 1.52
Brain lesions and cognitive function in late-life psychosis. Br J Psychiatry (1991) 1.46
In vitro synthesis of IgE by human lymphocytes. III. IgE-potentiating activity of culture supernatants from Epstein-Barr virus (EBV) transformed B cells. Immunology (1984) 1.44
Post-tetanic potentiation and facilitation of synaptic potentials evoked in cat spinal motoneurones. J Physiol (1981) 1.44
Angiogram negative subarachnoid haemorrhage: outcomes and the role of repeat angiography. Clin Neurol Neurosurg (2013) 1.43
Ketamine has equal affinity for NMDA receptors and the high-affinity state of the dopamine D2 receptor. Biol Psychiatry (2001) 1.42
Primary intrasellar germinoma presenting with cavernous sinus syndrome. Surg Neurol (1988) 1.37
Patient-specific electromechanical models of the heart for the prediction of pacing acute effects in CRT: a preliminary clinical validation. Med Image Anal (2011) 1.37
Reversible drug-induced parkinsonism. Clinicopathologic study of two cases. Arch Neurol (1982) 1.36
Binding and internalization of heparin by vascular smooth muscle cells. J Cell Physiol (1985) 1.35
Antipsychotic agents differ in how fast they come off the dopamine D2 receptors. Implications for atypical antipsychotic action. J Psychiatry Neurosci (2000) 1.35
NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D(2) and serotonin 5-HT(2)receptors-implications for models of schizophrenia. Mol Psychiatry (2002) 1.33
Calcium reversal of nerve blockade by alcohols, anesthetics, tranquilizers, and barbiturates. Can J Physiol Pharmacol (1974) 1.31
The site of action of caffeine and procaine in skeletal muscle. J Pharmacol Exp Ther (1971) 1.29
Membrane expansion of the erythrocyte by both the neutral and ionized forms of chlorpromazine. Biochim Biophys Acta (1969) 1.29
Bimodal distribution of dopamine receptor densities in brains of schizophrenics. Science (1984) 1.28
Peripheral and central hypomyelination with hypogonadotropic hypogonadism and hypodontia. Neurology (2006) 1.28
Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor gamma. J Clin Invest (1996) 1.28
New detection of brain dopamine receptors with (3H)dihydroergocryptine. Proc Natl Acad Sci U S A (1977) 1.28
The membrane concentrations of alcohol anesthetics. Biochim Biophys Acta (1971) 1.27
Increased dopamine D2 receptor binding after long-term treatment with antipsychotics in humans: a clinical PET study. Psychopharmacology (Berl) (2000) 1.25
The adipocyte specific transcription factor C/EBPalpha modulates human ob gene expression. Proc Natl Acad Sci U S A (1996) 1.23
Structure of membrane holes in osmotic and saponin hemolysis. J Cell Biol (1973) 1.21
Membrane expansion of intact erythrocytes by anesthetics. Biochim Biophys Acta (1969) 1.19
Binding of 3H-neuroleptics and 3H-apomorphine in schizophrenic brains. Nature (1978) 1.19
Dopamine D2 receptor dimers and receptor-blocking peptides. Biochem Biophys Res Commun (1996) 1.18
High-pressure liquid chromatographic quantitation of rifampin and its two major metabolites in urine and serum. Rev Infect Dis (1983) 1.18
The effect of membrane-strain rate and of temperature on erythrocyte fragility and critical hemolytic volume. Biochim Biophys Acta (1969) 1.14
Synthesis of wild type and mutant human hemoglobins in Saccharomyces cerevisiae. Biotechnology (N Y) (1991) 1.14
Direct evidence for presynaptic and postsynaptic dopamine receptors in brain. Nature (1978) 1.13
Research methods of the Youth Smoking Survey (YSS). Chronic Dis Inj Can (2011) 1.12
Resolution of dopamine and serotonin receptor components of [3H]spiperone binding to rat brain regions. Proc Natl Acad Sci U S A (1981) 1.12
Multiple receptors for brain dopamine. Proc Natl Acad Sci U S A (1978) 1.11
Association of protein kinase Cmu with type II phosphatidylinositol 4-kinase and type I phosphatidylinositol-4-phosphate 5-kinase. J Biol Chem (1998) 1.11
Induction of c-myc transcription by the v-Abl tyrosine kinase requires Ras, Raf1, and cyclin-dependent kinases. Genes Dev (1997) 1.10
Disposition of the flame retardant, tris(1,3-dichloro-2-propyl) phosphate, in the rat. Drug Metab Dispos (1982) 1.10
The functional state of the dopamine receptor in the anterior pituitary is in the high affinity form. Endocrinology (1985) 1.10
Liposome-complement interactions in rat serum: implications for liposome survival studies. Biochim Biophys Acta (1994) 1.10
L-DOPA reversal of hyperdopaminergic behaviour. Life Sci (1978) 1.09
Sperm shape abnormalities in carbaryl-exposed employees. Environ Health Perspect (1981) 1.08
Epstein-Barr virus genome in thymoma and thymic lymphoid hyperplasia. Am J Pathol (1988) 1.06
Use of fluoride ion as a probe for the guanine nucleotide-binding protein involved in the phosphoinositide-dependent neutrophil transduction pathway. FEBS Lett (1986) 1.05
Effect of ethanol on cytochrome P450 2E1 (CYP2E1), lipid peroxidation, and serum protein adduct formation in relation to liver pathology pathogenesis. Exp Mol Pathol (1993) 1.05
Inhibition of the n-formylmethionyl-leucyl-phenylalanine induced respiratory burst in human neutrophils by adrenergic agonists and prostaglandins of the E series. Can J Physiol Pharmacol (1981) 1.05
A transmembrane domain-derived peptide inhibits D1 dopamine receptor function without affecting receptor oligomerization. J Biol Chem (1998) 1.04
Treatment of ulcerative colitis with adalimumab or infliximab: long-term follow-up of a single-centre cohort. Aliment Pharmacol Ther (2010) 1.04
Enhanced dopamine function in DISC1-L100P mutant mice: implications for schizophrenia. Genes Brain Behav (2010) 1.04
The nerve impulse-blocking actions of tranquilizers and the binding of neuroleptics to synaptosome membranes. J Pharmacol Exp Ther (1974) 1.03